TScan Therapeutics' departing CEO David Southwell and CSO/COO Gavin MacBeath
TCR upstart announces CEO exit, with CSO now acting replacement
A public T cell biotech’s chief executive has decided to leave the company.
TScan Therapeutics said Friday morning that CEO David …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
